The role of cetuximab in the management of head and neck cancers

By Kabolizadeh Peyman   Kubicek Gregory J   Heron Dwight E   Ferris Robert L   Gibson Michael K  

Expert Opinion on Biological Therapy, Vol. 12, Iss. 4, 2012-04 ,pp. : 517-528

Informa Healthcare

Access to resources Recommend Favorite

Role of functional polymorphism of matrix metalloproteinase-2 (-1306 C/T and -168 G/T) and MMP-9 (-1562 C/T) promoter in oral submucous fibrosis and head and neck squamous cell carcinoma in an Indian population

By Chaudhary Ajay Kumar   Pandya Shruti   Mehrotra Ravi   Singh Mangal   Singh Mamta  

Biomarkers, Vol. 16, Iss. 7, 2011-11 ,pp. : 577-586

Informa Healthcare

Access to resources Recommend Favorite

Zalutumumab in head and neck cancer

By Schick Ulrike   Gujral Dorothy M   Richards Tom M   Harrington Kevin J   Nutting Christopher M  

Expert Opinion on Biological Therapy, Vol. 12, Iss. 1, 2012-01 ,pp. : 119-125

Informa Healthcare

Access to resources Recommend Favorite

Polymorphism in glutathione S-transferases: Susceptibility and treatment outcome for head and neck cancer

By Ruwali Munindra   Singh Madhu   Pant Mohan C.   Parmar Devendra  

Xenobiotica, Vol. 41, Iss. 12, 2011-12 ,pp. : 1122-1130

Informa Healthcare

Access to resources Recommend Favorite

Targeting head and neck squamous cell carcinoma using a novel fusion toxin-diphtheria toxin/HN-1

By Potala Sirisha   Verma Rama  

Molecular Biology Reports, Vol. 38, Iss. 2, 2011-02 ,pp. : 1389-1397

Springer Publishing Company

Access to resources Recommend Favorite